 |
인쇄하기
취소
|
Patent court rules against Sanofi-Aventis in patent suit
A patent court on Wednesday dismissed claims by French drug maker Sanofi-Aventis SA in a patent lawsuit against Boryung Pharmaceutical over their generic cancer medicine.
The court upheld the Korean Intellectual Property Tribunal’s rulings in favor of Boryung, who say Byrung’s generic drug for cancer treatment doesn’t infringe on a Sanofi-Aventis patent.
Boryung filed the lawsuit with the...
The court upheld the Korean Intellectual Property Tribunal’s rulings in favor of Boryung, who say Byrung’s generic drug for cancer treatment doesn’t infringe on a Sanofi-Aventis patent.
Boryung filed the lawsuit with the...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.